Nath Bio-Genes (India) Ltd (NSE: NATHBIOGEN, BSE: 537291) is a Mumbai, Maharashtra-based company in the Grain And Field Beans industry. With a market capitalisation of ₹266 Cr, it ranks #2,430 by market cap among the 6,197 Indian listed companies on FinBizNet, and #13 of 38 in Grain And Field Beans. At ₹142.00 (as of 16 Nov 2026), the share price is 30.4% below its 52-week high of ₹204.00 and 12.6% above its 52-week low of ₹126.15. The share price is down 17.2% over one year and down 8.6% over three months.
| Current Price | ₹142.00 |
|---|---|
| Market Cap | ₹266 Cr |
| NSE Symbol | NATHBIOGEN |
| BSE Code | 537291 |
| Sector | Consumer Staples > Food, Beverage and Tobacco > Food Products |
| Sub-Industry | Agricultural Products and Services > Grain And Field Beans |
| P/E Ratio | 6.4 |
| Return on Equity | 6.28% |
| Return on Assets | 2.87% |
| 52-Week Range | ₹126.15 – ₹204.00 |
| 1-Year Price Change | -17.2% |
| 3-Month Price Change | -8.6% |
| Beta (1Y) | 0.17 |
| Dividend Yield | 1.43% |
| Headquarters | Mumbai, Maharashtra |
| Website | nathbiogenes.com |
| Revenue | ₹41 Cr |
|---|---|
| Net Profit | ₹0 Cr |
| Net Margin | 1.0% |
| EPS (Basic) | ₹0.22 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Nath Bio-Genes (India) Ltd reported revenue of ₹41 Cr in Q2 FY27, down 7.1% from ₹44 Cr in Q2 FY26 and down 87.6% from ₹328 Cr in Q1 FY27. It posted a net profit of ₹0 Cr for the quarter, against a net profit of ₹3 Cr in Q2 FY26 (down 84.7%). Across the 6 quarters from Q1 FY26 to Q2 FY27, quarterly revenue ranged from ₹41 Cr (Q2 FY27) to ₹328 Cr (Q1 FY27). The company reported a net loss in 1 of these 6 quarters.
| Quarter | Revenue | Net Profit | Net Margin |
|---|---|---|---|
| Q2 FY27 | ₹41 Cr | ₹0 Cr | 1.0% |
| Q1 FY27 | ₹328 Cr | ₹32 Cr | 9.8% |
| Q4 FY26 | ₹52 Cr | −₹0 Cr | −0.0% |
| Q3 FY26 | ₹66 Cr | ₹2 Cr | 2.4% |
| Q2 FY26 | ₹44 Cr | ₹3 Cr | 6.3% |
| Q1 FY26 | ₹284 Cr | ₹37 Cr | 13.1% |
Consolidated figures (₹ crore, XBRL filings).
Promoters held 45.60% of Nath Bio-Genes (India) Ltd's shares as of Sept 2026, unchanged from Sept 2025. Delivery averaged 74.5% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).
Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers fiber and oil seeds, including cotton and mustard; seeds for field crops, such as bajra, corn, paddy, wheat, and jowar; fruit seeds; and seeds for vegetables comprising cabbage, chilli, onion, okra, tomato, brinjal, bottle gourd, bitter gourd, sponge gourd, ridge gourd, cucumber, coriander, sweet pepper, green peas, pumpkin, tinda, and French beans. It also provides crop protection supplements under the WINPro GOLii, WINall, and Win-Chi-Win names; and forage seeds under the NUTRIMAX GOLD and NUTRIMAX names. The company was founded in 1979 and is based in Mumbai, India.
1. Agriculture Activities-This segment engages in the seed production business. 2. Trading Activities-This segment engages in trading activities. 3. Research, Production and Processing of Seeds-This segment produces and sells seeds in India. It offers seeds for cereals, such as maize, paddy, pearl millet, sorghum, and wheat seeds; fiber and oil seeds, including cotton, mustard, and sunflower seeds; and seeds for vegetables comprising bitter gourd, bottle gourd, cabbage, cauliflower, chilly, coriander, cucumber, egg plant, okra, onion, ridge gourd, sponge gourd, tomato, and watermelon seeds.
1. Trading Activities-8.5% 2. Agriculture Activities-91.5%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Lt Foods Ltd. | ₹14,963 Cr | 24 | 14.94% | ₹3,234 Cr | +5.0% |
| Godrej Agrovet Ltd | ₹11,276 Cr | 24.1 | 18.68% | ₹2,995 Cr | +0.5% |
| KRBL Ltd | ₹9,509 Cr | 14.9 | 11.73% | ₹1,727 Cr | +12.7% |
| Gujarat Ambuja Exports | ₹6,919 Cr | 22.5 | 9.66% | ₹1,451 Cr | +32.7% |
| Grm Overseas Ltd. | ₹1,947 Cr | 24.6 | 14.38% | ₹453 Cr | -39.4% |
| Chaman Lal Setia Exports Ltd | ₹1,481 Cr | 12.9 | 14.61% | ₹329 Cr | +10.8% |
| Bombay Super Hybrid Seeds Ltdte | ₹951 Cr | 34.8 | 22.68% | ₹86 Cr | -25.6% |
| Mangalam Global Enterprise Limited (Mgel) | ₹582 Cr | 12.9 | 20.39% | ₹983 Cr | +23.1% |
| Nath Bio-Genes (India) Ltd | ₹266 Cr | 6.4 | 6.28% | ₹41 Cr | -17.2% |
Listed by market capitalisation. Ratios are shown for context only.
Nath Bio-Genes (India) Ltd is trading at ₹142.00, with a market capitalisation of ₹266 Cr.
Nath Bio-Genes (India) Ltd operates in the Consumer Staples > Food, Beverage and Tobacco > Food Products space (Agricultural Products and Services > Grain And Field Beans).
Nath Bio-Genes (India) Ltd has a P/E of 6.4 and a return on equity of 6.28%.
Nath Bio-Genes (India) Ltd is listed on the NSE under the symbol NATHBIOGEN and on the BSE under the scrip code 537291.
Nath Bio-Genes (India) Ltd's share price is down 17.2% over one year and down 8.6% over three months. Its 52-week range is ₹126.15 to ₹204.00.
In Q2 FY27, Nath Bio-Genes (India) Ltd reported revenue of ₹41 Cr and net profit of ₹0 Cr, with basic EPS of ₹0.22 (consolidated, parsed from the company's exchange filing).
Nath Bio-Genes (India) Ltd reported revenue of ₹41 Cr in Q2 FY27, down 7.1% from ₹44 Cr in Q2 FY26 and down 87.6% from ₹328 Cr in Q1 FY27.
Promoters held 45.60% of Nath Bio-Genes (India) Ltd's shares as of Sept 2026, unchanged from Sept 2025.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.